Field study of the prevalence of lameness in horses with back problems

A population of 805 horses (70 per cent dressage, 20 per cent show jumpers and 10 per cent trotters) with orthopaedic problems was examined for signs of lameness and back problems, irrespective of their original complaints. In the horses with a back problem the prevalence of lameness was 74 per cent, and back problems were diagnosed in 32 per cent of the lame horses. These percentages were significantly higher than those recorded in a control population of 399 horses, of which 20 per cent were lame and 12 per cent had back problems. In the group of horses with orthopaedic problems there was a strong association between lameness and back problems and, in particular, there was a high prevalence of lameness among the horses with back problems.     

Pharmacokinetic-Pharmacodynamic Modelling of Danofloxacin in Turkeys

Colibacillosis is a systemic disease responsible for important economic losses in poultry breeding; fluoroquinolones, including danofloxacin, are used to treat diseased animals. The purpose of the present study was to estimate pharmacokinetic–pharmacodynamic (PK-PD) surrogates for bacteriostasis, bactericidal activity and bacterial elimination against Escherichia coli O78/K80, using a PK-PD approach, for danofloxacin in turkeys after oral administration. Eight healthy turkeys, breed BUT 9, were included in a two-way crossover study. The drug was administered intravenously (i.v.) and orally at a dose rate of 6 mg/kg bw. The values of the elimination half-life and the total body clearance after i.v. administration were 8.64 ± 2.35 h and 586.76 ± 136.67 ml kg^-1h^-1, respectively. After oral administration, the values of the absolute bioavailability and the elimination half-life were 78.37± 17.35% and 9.74± 2.93 h, respectively. The minimum inhibitory concentration against the investigated strain in turkey serum was 0.25 μg/ml, four times higher than in broth. The lowest effective ex vivo AUC₂₄/MIC ratios required for bacteriostasis, bactericidal activity, and total killing of E. coliO78/K80 were 0.416 h, 1.9 h and 6.73 h, respectively. The oral dose of 6 mg/kg used in the present study could be interpreted as being sufficient to eliminate E. coli with an MIC 0.25 μ g/ml. However, considering the demand that antimicrobial resistance should be avoided by complete bacterial elimination, PK-PD considerations suggest that an even higher dose of 32 mg/kg per day or 0.7 mg/kcal per day should be evaluated in clinical trials.     

Working towards a reduction in cattle lameness: 1. Understanding barriers to lameness control on dairy farms

On 222 dairy farms, the farmer’s perception of the scale of the herd lameness problem was compared with the prevalence detected by observation of the milking herd, and a questionnaire explored the barriers to lameness reduction. Ninety percent of farmers did not perceive lameness to be a major problem on their farm, although the average prevalence of lameness was 36%. For 62% of the sample, lameness was not the top priority for efforts made to improve herd health. Time and labour were important limiting factors for lameness control activities and financial constraints prevented farmers taking action on advice in 30% of cases. Farmers’ understanding the implications of lameness for the farm business was limited. Lameness reduction is restricted by farmers’ perception of lameness, but also by time, labour and finance; these issues need to be addressed at the industry level to support animal welfare improvement.     

Interval between detection of lameness by locomotion scoring and treatment for lameness: A survival analysis

Estimates of point prevalence suggest that locomotion scoring identifies three times as many lame cows than when estimated by farmers. The aim of this study was to ascertain the impact of this under-recognition on the interval between identification of lameness (using locomotion score) and treatment. The study was undertaken on a 463-cow, spring-calving, pasture-fed herd in the lower North Island of New Zealand. All cows were locomotion scored (using a 1-5 scale) weekly during one milking season (July 2008 to May 2009). Survival analyses were then used to quantify the number of days between identification of a specific locomotion score and presentation, by farm staff, of a cow for lameness treatment. All cows which had a locomotion score of >3 were presented for lameness treatment subsequently, although >40% were treated more than 3weeks after being identified. Only 75% of events where cows had a locomotion score of 3 were followed by treatment with >65% of those treatments occurring >3weeks after the first score of 3. Improving the recognition of lameness by farm staff is thus likely to appreciably reduce the interval between reduced mobility and lameness treatment.     

Incidence of lameness in dairy cows

A survey of the number of treatments for lameness in 21,000 dairy cows from 185 herds in the University of Edinburgh/Dalgety Spillers dairy herd health and productivity service in England and Wales showed an average incidence of cases of 25 per cent. Veterinary surgeons treated 6.3 per cent and farmers 18.7 per cent and 1.4 per cent of cows were culled because of lameness. Monthly and regional variations were recorded. An assessment of the economic effects suggested that the average annual cost in a 100 cow herd was 1175 pounds with an overall cost to British farmers of more than 35 million pounds. The economic importance is such that research into specific factors affecting foot health should be carried out. Meanwhile, a broad approach to prevention and control of lameness on farms is recommended under the general headings of management/environment, nutrition and breeding.     

Salmonellosis in Turkeys: Evaluation of Bacteriological and Serological Evidence of Infection

Bacteriological and serological studies were made of Salmonella infections in turkeys under three conditions; in commercial hatchery supply flocks and their embryo and poult progeny, in survivors of a natural infection over a ten-month period, and in experimentally infected adult turkeys.

The investigations revealed the following: 1. Carrier birds yielded Salmonella from cloacal swabs only intermittently which emphasized that failure to so isolate the organism did not necessarily indicate absence of infection in flocks. On the other hand, recovery of Salmonella from swabs or from dead-in-shell embryos foretold the likelihood of clinical disease in the progeny.

2. Bacteriological examination of ten per cent of the embryos from infected individual hatches did not regularly yield Salmonella but culture of a series of hatches revealed the disease status of the progeny.

3. The percentage of infected embryos in one hatchery which frequently disseminated S. typhimurium was estimated to range from two to twenty per cent in different hatches.

4. Environmental sanitation in the flock and hatchery appeared to be a major influence in the frequency of clinical outbreaks in the poults.

5. Two hatchery supply flocks were found to be infected with at least two serotypes; a third serotype appeared in the progeny of one in addition to the two in the parent flock.

6. Hatchery supply flocks with no history of clinical infection but having a latent infection transmitted the disease as readily as those which had survived clinical outbreaks.

7. The overall performance of the bacterial agglutination and hemagglutination tests demonstrated an equal but unsatisfactory degree of efficacy insofar as detection of infected birds was concerned. Both tests failed to identify half of the infected birds and also one infected flock.

8. A high incidence of non-specific reactions was observed in the hemagglutination tests of sera from non-infected birds. The number was greatly reduced by selecting strains whose extracts were more suitable for modifying erythrocytes. The possibility of the practical application of this test as a screening procedure would appear to depend on overcoming the problem arising from frequent non-specific reactions.

     

Comparisons of computed tomography, contrast-enhanced computed tomography and standing low-field magnetic resonance imaging in horses with lameness localised to the foot. Part 2: Lesion identification

Reasons for performing study: No previous study compares computed tomography (CT), contrast‐enhanced computed tomography (CECT) and standing low‐field magnetic resonance imaging (LFMRI) to detect lesions in horses with lameness localised to the foot. This study will help clinicians understand the limitations of these techniques. Objectives: To determine if CT, CECT and LFMRI would identify lesions within the distal limb and document discrepancies with lesion distribution and lesion classification. Methods: Lesions in specific structures identified on CT and MR images of feet (31 limbs) from the same horse were reviewed and compared. Distributions of lesions were compared using a Chi‐squared test and techniques analysed using the paired marginal homogeneity test for concordance. Results: Lesions of the deep digital flexor tendon (DDFT) were most common and CT/CECT identified more lesions than LFMRI. Deep digital flexor tendon lesions seen on LFMRI only were frequently distal to the proximal extent of the distal sesamoid and DDFT lesions seen on CT/CECT only were frequently proximal to the distal sesamoid. Lesions identified on LFMRI only were core (23.3%) or splits (43.3%), whereas lesions identified only on CT were abrasions (29.8%), core (15.8%), enlargement (15.8%) or mineralisation (12.3%). Contrast‐enhanced CT improved lesion identification at the DDFT insertion compared to CT and resulted in distal sesamoidean impar ligament and collateral sesamoidean ligament vascular enhancement in 75% of cases. Low‐field MRI and CT/CECT failed to identify soft tissue mineralisation and bone oedema, respectively. Conclusions and potential relevance: Multiple lesions are detected with CT, CECT and LFMRI but there is variability in lesion detection and classification. LFMRI centred only on the podotrochlear apparatus may fail to identify lesions of the pastern or soft tissue mineralisation. Computed tomography may fail to identify DDFT lesions distal to the proximal border of the distal sesamoid.     

Formulation and (bio)availability problems of drug formulations in birds.

Most drugs used for the treatment of birds are not formulated for birds. Therefore the availability of drugs for birds and their administration routes largely depend on formulations available for man, mammals and to some extent poultry. The problems with the application of existing formulations, the drug concentrations and the many different avian species are discussed. The desire of the avian veterinarian for the combination of several active compounds presents special problems. This again requires extra data on the interactions in galenic, pharmaceutic, pharmacokinetic and dynamic phases, which are generally not readily available.     

Prevention of lameness in cow-calf operations.

Lameness is a significant cause of economic loss, premature culling, and loss of genetics in cow-calf operations. In recent years, attention to treatment and prevention of lameness has increased. Veterinarians must be aware of factors associated with lameness such as genetics, environment, and nutrition so that preventive measures can be instituted in consultation with ranchers.